Computer-based antiviral drug development: targeting CDKs/vCDKs as crucial determinants of cytomegalovirus and Epstein-Barr virus infections (GRK 2504 A1)

Third Party Funds Group - Sub project


Acronym: GRK 2504 A1

Start date : 01.01.2019

End date : 31.03.2024

Extension date: 30.09.2028

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Molecular Characterization of the GALC Mutation Thr112Ala Causing Krabbe Disease (2025) Heger L, Ankermann P, Socher E Journal article